Top Markets
Coin of the day
Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL
Rang in Aktien #40577
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Aktienkurs
$0.0036163
Zuletzt synchronisiert: 2023-10-30
Marktkapitalisierung
$118.21K
Veränderung (1 Tag)
0.39%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Canntab Therapeutics Limited (PILL)

Kategorie

Aktien-Split-Historie für Canntab Therapeutics Limited (PILL)
Die Aktie Canntab Therapeutics Limited (Symbol: PILL) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 13, 2026 statt.
Eine PILL-Aktie, die vor dem Aug 13, 2026 gekauft wurde, entspricht heute 0 PILL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber